New York, NY (PRWEB) October 31, 2013
The medication safety advocates at DrugNews.net are alerting patients taking the blood thinner Pradaxa of new information on the site. A recent study ranked the drug top among all medications for reports of serious side effects like internal bleeding*.
DrugNews offers the latest information on recalls, safety alerts, research and litigation news to those patients taking popular prescription drugs. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.
Pradaxa is a blood thinner approved by the FDA in 2010 as a stroke preventative for patients with atrial fibrillation. While the FDA has stated Pradaxa is as safe as traditional blood thinner warfarin**, other experts disagree.
The Institute for Safe Medication Practices has warned that patients may be nearly 5 times as likely to die from Pradaxa bleeding than from warfarin bleeding***. A study this year from the Netherlands also suggests patients taking newer blood thinners like Pradaxa may be 55% more likely to suffer internal bleeding****.
Now, DrugNews has learned that the latest study from the Institute for Safe Medication Practices found that Pradaxa had the highest number of side effect complaints to the FDA last year, with 683 reports of bleeding*.
Due to the amount of patients who have filed a Pradaxa lawsuit alleging internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. The latest court records show as many as 1,643 cases have been filed as of October 17*****.
Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit DrugNews.net or speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugNews only recommends lawyers who have already handled Pradaxa lawsuits.
Visit http://www.DrugNews.net today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.
*Institute for Safe Medication Practices, 10/17/13; ismp.org/quarterwatch/pdfs/2012Q4.pdf
**FDA, 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****Gastroenterology, July 2013; gastrojournal.org/article/S0016-5085(13)00290-4/fulltext
*****Judicial Panel on Multidistrict Litigation, 10/17/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-October-17-2013.pdf